New pharmacological options in the treatment of Alzheimer's disease

被引：2
|
作者：
Kleinova, L. [1 ,2 ]
Cerman, J. [2 ]
Hlavka, J. [3 ]
Hort, J. [2 ]
机构：
[1] 1 LF UK, Vseobecne Lekarstvi, Prague, Czech Republic
[2] Neurol Klin 2 LF UK, Kognitivni Ctr, V Uvalu 84, Prague 15006, Czech Republic
[3] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA
来源：
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE | 2022年 / 85卷 / 06期
关键词：
Alzheimer?s disease; phase three testing  of new drugs; β -amyloid; tau protein; neuroinflammatory theory; ric symptoms; neuroprotection; BETA; TRAMIPROSATE; INHIBITION; GUANFACINE; DEMENTIA; TRIAL;
D O I：
10.48095/cccsnn2022462
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
A new era of innovative treatment options for Alzheimer's disease is emerging. New goals of treatment are being developed with various monoclonal antibodies targeting potentially pathological molecules involved in the pathogenesis of Alzheimer's disease. The aim of this review is to acquaint the reader with new potential drugs, while most of those mentioned in this review are in the third phase of clinical trials.
引用
收藏
页码：462 / 469
页数：8
相关论文
共 50 条
  • [41] Advancements in Pharmacological Treatment of Alzheimer's Disease: The Advent of Disease-Modifying Therapies (DMTs)
    Wang, Qiong
    Chen, Sihui
    Wang, Junhui
    Shang, Huifang
    Chen, Xueping
    BRAIN SCIENCES, 2024, 14 (10)
  • [42] Pharmacological Treatment of Alzheimer's Disease: Insights fromDrosophila melanogaster
    Cheng, Xingyi
    Song, Chaochun
    Du, Yanjiao
    Gaur, Uma
    Yang, Mingyao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 17
  • [43] Non-pharmacological treatment of Alzheimer's disease: an update
    Wang, Shaofen
    Xu, Haochen
    Liu, Guangdong
    Chen, Limei
    FRONTIERS IN AGING NEUROSCIENCE, 2025, 17
  • [44] Pharmacological Treatment of Depression in Alzheimer's Disease: A Challenging Task
    Cassano, Tommaso
    Calcagnini, Silvio
    Carbone, Antonio
    Bukke, Vidyasagar Naik
    Orkisz, Stanislaw
    Villani, Rosanna
    Romano, Adele
    Avolio, Carlo
    Gaetani, Silvana
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [45] The pharmacological treatment of behavioral and psychological symptoms of Alzheimer's disease
    Alexopoulos, P.
    Gourzis, P.
    ARCHIVES OF HELLENIC MEDICINE, 2008, 25 (06): : 707 - 719
  • [46] Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease
    Ozben, Tomris
    Ozben, Serkan
    CLINICAL BIOCHEMISTRY, 2019, 72 : 87 - 89
  • [47] Efficacy of memantine in the treatment of Alzheimer's disease
    Guix, JLM
    Plarrumaní, AL
    NEUROLOGIA, 2005, 20 (10): : 686 - 691
  • [48] Current pharmacologic options for patients with Alzheimer's disease
    William E Reichman
    Annals of General Hospital Psychiatry, 2 (1):
  • [49] An update on the pharmacological treatment of Alzheimer disease
    Fuentes, P
    Slachevsky, A
    REVISTA MEDICA DE CHILE, 2005, 133 (02) : 224 - 230
  • [50] Targeting New Pharmacological Approaches for Alzheimer's Disease: Potential for Statins and Phosphodiesterase Inhibitors
    Sallustio, Fabrizio
    Studer, Valeria
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (06) : 647 - 659
12345